Ehrenforth S, Junker R, Koch H G, Kreuz W, Münchow N, Scharrer I, Nowak-Göttl U
Department of Internal Medicine, University Hospital Frankfurt, Germany.
Eur J Pediatr. 1999 Dec;158 Suppl 3:S97-104. doi: 10.1007/pl00014359.
To evaluate the role of multiple established and potential causes of childhood thrombophilia, 285 children with a history of thrombosis aged neonate to 18 years (first thrombotic onset) were investigated and compared with 185 healthy peers. APC-resistance (FV:Q506), protein C, protein S, antithrombin, heparin cofactor II (HCII), histidine-rich glycoprotein (HRGP), and prothrombin (F.II), factor XII (F.XII), plasminogen, homocysteine and lipoprotein (a) (Lp(a)) were investigated. In 59% of patients investigated one thrombotic defect was diagnosed, 19.6% showed two thrombotic risk factors, while in 21.4% of children investigated no risk factor could be identified. Single defects comprised established causes of inherited thrombophilia: FV:Q506 (homozygous n = 10, heterozygous n = 69), protein C (homozygous n = 1; heterozygous n = 31), heterozygous type I deficiency states of protein S (n = 7), antithrombin (n = 7) and homocystinuria (n = 6); potentially inherited clotting abnormalities which may be associated with thrombophilia: F.XII (n = 3), plasminogen (n = 2), HCII (n = 1), increased HRGP (n = 4); new candidate risk factors for thrombophilia: elevated plasma levels of Lp(a) (n = 26), F.II (n = 1). Heterozygous FV:Q506 was found in combination with heterozygous type I deficiency states of protein C (n = 2), protein S (n = 13), antithrombin (n = 8) and HCII (n = 1), increased Lp(a) (n = 13), and once each with elevated levels of F.II, moderate hyperhomocysteinemia, fibrinogen concentrations > 700 mg/dl and increased HRGP. In addition to the association with FV:Q506, heterozygous protein C type I deficiency was combined with deficiencies of protein S (n = 2), antithrombin (n = 1), and increased Lp(a) (n = 3). One patient showed protein C deficiency along with familially increased von Willebrand factor > 250%. Besides coexistence with FV:Q506 and protein C deficiency, protein S deficiency was combined with decreased F.XII and increased Lp(a) in one subject each. Furthermore, we found combinations of antithrombin deficiency/elevated Lp(a), hyperhomocysteinemia/Lp(a), deficiency of HCII/plasminogen, and plasminogen deficiency along with increased Lp(a) each in one. Increased prothrombin levels were associated with fibrinogen concentrations > 700 mg/dl and with HCII deficiency in one child each. Carrier frequencies of single and combined defects were significantly higher in patients compared with the controls.
In conclusion, data of this multicentre evaluation indicate that paediatric thromboembolism should be viewed as a multifactorial disorder.
为评估多种已确定的和潜在的儿童血栓形成原因的作用,对285名有血栓形成病史的新生儿至18岁儿童(首次血栓形成发作)进行了调查,并与185名健康同龄人进行比较。检测了活化蛋白C抵抗(FV:Q506)、蛋白C、蛋白S、抗凝血酶、肝素辅因子II(HCII)、富含组氨酸糖蛋白(HRGP)、凝血酶原(F.II)、因子XII(F.XII)、纤溶酶原、同型半胱氨酸和脂蛋白(a)(Lp(a))。在接受调查的患者中,59%被诊断出一种血栓形成缺陷,19.6%有两种血栓形成危险因素,而在21.4%接受调查的儿童中未发现危险因素。单一缺陷包括遗传性血栓形成的已确定原因:FV:Q506(纯合子n = 10,杂合子n = 69)、蛋白C(纯合子n = 1;杂合子n = 31)、蛋白S杂合子I型缺乏状态(n = 7)、抗凝血酶(n = 7)和同型胱氨酸尿症(n = 6);可能与血栓形成有关的潜在遗传性凝血异常:F.XII(n = 3)、纤溶酶原(n = 2)、HCII(n = 1)、HRGP升高(n = 4);血栓形成的新候选危险因素:血浆Lp(a)水平升高(n = 26)、F.II(n = 1)。发现杂合子FV:Q506与蛋白C杂合子I型缺乏状态(n = 2)、蛋白S(n = 13)、抗凝血酶(n = 8)和HCII(n = 1)、Lp(a)升高(n = 13)联合存在,并且分别与F.II水平升高、中度高同型半胱氨酸血症、纤维蛋白原浓度>700mg/dl和HRGP升高各联合存在一次。除了与FV:Q506相关外,蛋白C杂合子I型缺乏还与蛋白S缺乏(n = 2)、抗凝血酶缺乏(n = 1)和Lp(a)升高(n = 3)联合存在。一名患者表现为蛋白C缺乏以及家族性血管性血友病因子升高>250%。除了与FV:Q506和蛋白C缺乏共存外,蛋白S缺乏在一名受试者中分别与F.XII降低和Lp(a)升高联合存在。此外,我们还发现抗凝血酶缺乏/Lp(a)升高、高同型半胱氨酸血症/Lp(a)、HCII缺乏/纤溶酶原缺乏以及纤溶酶原缺乏与Lp(a)升高各联合存在于一名患者中。凝血酶原水平升高在一名儿童中分别与纤维蛋白原浓度>700mg/dl和HCII缺乏相关。患者中单一和联合缺陷的携带频率显著高于对照组。
总之,这项多中心评估的数据表明,儿童血栓栓塞应被视为一种多因素疾病。